Wave life sciences to present at upcoming investor conferences

Cambridge, mass., march 27, 2024 (globe newswire) -- wave life sciences ltd. (nasdaq: wve), a clinical-stage biotechnology company focused on unlocking the broad potential of rna medicines to transform human health, today announced that paul bolno, md, mba, president and chief executive officer, is scheduled to participate in two upcoming investor conferences in april.
WVE Ratings Summary
WVE Quant Ranking